Diffusion of Hiv Infection Through Sexual Risk Behaviors of Drug Users
The summary for the Diffusion of Hiv Infection Through Sexual Risk Behaviors of Drug Users grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Diffusion of Hiv Infection Through Sexual Risk Behaviors of Drug Users: The purpose of this RFA is to stimulate collaborative research to further understanding of sexual transmission of HIV within and across drug-using population subgroups and to non-drug using populations. The National Institute on Drug Abuse (NIDA) invites cooperative agreement applications to participate in the Sexual Acquisition and Transmission of HIV Cooperative Agreement Program (SATH-CAP). The goal of this cooperative research program is to support multi-disciplinary research that seeks to better understand the dynamic behavioral, biological, and environmental processes implicated in the sexual transmission of HIV and other sexually transmitted infections (STI) among drug users and the diffusion of infections from drug using populations to non-drug using populations. The SATH-CAP will include a Coordinating Center and multiple Research Centers that will work in concert with other centers, their respective sites, and with NIDA to conduct multi-site collaborative research projects.
Federal Grant Title: | Diffusion of Hiv Infection Through Sexual Risk Behaviors of Drug Users |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health Education |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-DA-03-001 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.279 |
CFDA Descriptions: | Drug Abuse Research Programs |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Mar 20, 2003 |
Posted Date: | Dec 21, 2002 |
Creation Date: | Apr 19, 2003 |
Archive Date: | Apr 19, 2003 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
- Similar Government Grants
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
- • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
- • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
- • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...